These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 36480479)

  • 61. Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May-July 2022.
    van Ewijk CE; Smit C; Bavalia R; Ainslie K; Vollaard A; van Rijckevorsel G; Hahné SJM
    Vaccine; 2023 Nov; 41(47):6952-6959. PubMed ID: 37838481
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.
    Merad Y; Gaymard A; Cotte L; Perpoint T; Alfaiate D; Godinot M; Becker A; Cannesson O; Batalla AS; Oria-Yassir F; Landré S; Morfin F; Bouscambert M; Valour F; Ader F; Conrad A
    Euro Surveill; 2022 Dec; 27(50):. PubMed ID: 36695469
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration.
    Lucero-Obusan C; Oda G; Schirmer P; Edson C; Trevino C; Elbeik T; Holodniy M
    J Infect Dis; 2024 Mar; 229(Supplement_2):S172-S180. PubMed ID: 38134309
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of Smartphone Text Data Related to mpox from a U.S. Sample of Gay, Bisexual, and Other Men Who Have Sex with Men During the 2022 Outbreak.
    Cascalheira CJ; Hong C; Beltran RM; Karkkainen K; Beikzadeh M; Sarrafzadeh M; Holloway IW
    LGBT Health; 2023 Oct; 10(7):560-565. PubMed ID: 37219872
    [No Abstract]   [Full Text] [Related]  

  • 65. Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention.
    Kandeel M; Morsy MA; Abd El-Lateef HM; Marzok M; El-Beltagi HS; Al Khodair KM; Albokhadaim I; Venugopala KN
    Int Immunopharmacol; 2023 Jun; 119():110206. PubMed ID: 37087871
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mpox Diagnosis, Behavioral Risk Modification, and Vaccination Uptake among Gay, Bisexual, and Other Men Who Have Sex with Men, United Kingdom, 2022.
    Ogaz D; Enayat Q; Brown JRG; Phillips D; Wilkie R; Jayes D; Reid D; Hughes G; Mercer CH; Saunders J; Mohammed H;
    Emerg Infect Dis; 2024 May; 30(5):916-925. PubMed ID: 38573160
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Demographics and Health Beliefs of Black Gay, Bisexual, and Other Sexual Minority Men Receiving a Mpox Vaccination in the United States.
    Ogunbajo A; Euceda A; Smith J; Ekundayo R; Wattree J; Brooks M; Hickson D
    J Urban Health; 2023 Feb; 100(1):204-211. PubMed ID: 36662397
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Behavioral Intention of Receiving Monkeypox Vaccination and Undergoing Monkeypox Testing and the Associated Factors Among Young Men Who Have Sex With Men in China: Large Cross-Sectional Study.
    Luo S; Jiao K; Zhang Y; Xu Y; Zhou J; Huang S; Li Y; Xiao Y; Ma W; He L; Ren X; Dai Z; Sun J; Li Q; Cheng F; Liang W
    JMIR Public Health Surveill; 2024 Mar; 10():e47165. PubMed ID: 38502181
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidemiologic and Clinical Characteristics of Monkeypox Cases - United States, May 17-July 22, 2022.
    Philpott D; Hughes CM; Alroy KA; Kerins JL; Pavlick J; Asbel L; Crawley A; Newman AP; Spencer H; Feldpausch A; Cogswell K; Davis KR; Chen J; Henderson T; Murphy K; Barnes M; Hopkins B; Fill MA; Mangla AT; Perella D; Barnes A; Hughes S; Griffith J; Berns AL; Milroy L; Blake H; Sievers MM; Marzan-Rodriguez M; Tori M; Black SR; Kopping E; Ruberto I; Maxted A; Sharma A; Tarter K; Jones SA; White B; Chatelain R; Russo M; Gillani S; Bornstein E; White SL; Johnson SA; Ortega E; Saathoff-Huber L; Syed A; Wills A; Anderson BJ; Oster AM; Christie A; McQuiston J; McCollum AM; Rao AK; Negrón ME;
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(32):1018-1022. PubMed ID: 35951487
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
    Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ
    Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characteristics of JYNNEOS Vaccine Recipients Before and During a Large Multiday LGBTQIA+ Festival - Louisiana, August 9-September 5, 2022.
    Soelaeman RH; Mendoza L; McDonald R; Hand J; Sokol TM;
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1379-1381. PubMed ID: 36301814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness and Safety of the MVA-BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc).
    Back S; Knox B; Coakley C; Deltour N; Jacquot E; Raad H; Garry EM
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932380
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mpox Surveillance Based on Rash Characteristics - 13 Emergency Departments, United States, June-December 2023.
    Berdahl CT; Krishnadasan A; Pathmarajah K; Moran GJ; Torres JR; Waxman M; Mower W; Garner OB; Duvergne LP; Rimoin AW; Gorbach PM; Talan DA;
    MMWR Morb Mortal Wkly Rep; 2024 Jun; 73(22):507-513. PubMed ID: 38843078
    [TBL] [Abstract][Full Text] [Related]  

  • 74. JYNNEOS Vaccine for Mpox.
    Desai AN; Malani PN
    JAMA; 2023 Jun; 329(22):1995. PubMed ID: 37314274
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An overview on mRNA-based vaccines to prevent monkeypox infection.
    Natami M; Gorgzadeh A; Gholipour A; Fatemi SN; Firouzeh N; Zokaei M; Mohammed Ali SH; Kheradjoo H; Sedighi S; Gholizadeh O; Kalavi S
    J Nanobiotechnology; 2024 Mar; 22(1):86. PubMed ID: 38429829
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis.
    Pischel L; Martini BA; Yu N; Cacesse D; Tracy M; Kharbanda K; Ahmed N; Patel KM; Grimshaw AA; Malik AA; Goshua G; Omer SB
    Vaccine; 2024 Nov; 42(25):126053. PubMed ID: 38906763
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mpox vaccine and infection-driven human immune signatures.
    Cohn H; Bloom N; Cai G; Clark J; Tarke A; Bermúdez-González MC; Altman D; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
    medRxiv; 2023 Mar; ():. PubMed ID: 36945651
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.
    van Leeuwen LP; Shamier MC; Verstrepen BE; Götz HM; Schmitz KS; Akhiyate N; Wijnans K; Bogers S; van Royen ME; van Gorp EC; Koopmans MP; de Vries RD; GeurtsvanKessel CH; Zaeck LM
    Euro Surveill; 2024 Sep; 29(38):. PubMed ID: 39301741
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictors of Mpox vaccine uptake among sexual and gender minority young adults living in Illinois: Unvaccinated vs. double vs. single dose vaccine recipients.
    Curtis MG; Davoudpour S; Rodriguez-Ortiz AE; Felt D; French AL; Hosek SG; Phillips G; Serrano PA
    Vaccine; 2023 Jun; 41(27):4002-4008. PubMed ID: 37236817
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mpox on Reddit: a Thematic Analysis of Online Posts on Mpox on a Social Media Platform among Key Populations.
    Hong C
    J Urban Health; 2023 Dec; 100(6):1264-1273. PubMed ID: 37580545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.